Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc. SYDNEY, AUSTRALIA--(Marketwired - November 03, 2014) - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be...

Nuvilex, Inc. Moves Closer to "Bio-Artificial Pancreas" Diabetes Treatment With License for Insulin-Producing Cells NEW YORK, NY--(Marketwired - October 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has carefully mapped out its plan to develop a diabetes treatment using the Cell-in-a-Box® platform technology. It started...

New center at Kosair Children's Hospital will help transform lives of children with diabetes LOUISVILLE, KY., Nov. 14, 2013 (GLOBE NEWSWIRE) -- The Wendy L. Novak Diabetes Care Center at Kosair Children's Hospital has opened, offering children with Type 1 diabetes access to advanced treatment...

PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas DELRAY BEACH, Fla., March 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has...

New Diabetes Study by Cutting Edge Information Examines Drugs, Classes, and Market Leaders RESEARCH TRIANGLE PARK, NC--(Marketwire - January 6, 2010) - Cutting Edge Information (CEI) announces the release of its newest diabetes market forecast...